Joshua Patton, DO
Sports Medicine · Sylva, NCNPI 1033670617
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Arthrex at 33.0% of the total. Reporting peaked in 2024 at $1,783 and has fallen 79.6% since, to $364 in 2025.
Across 52 payments — averaging $82.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Peerless Surgical Inc.$1K
- Amgen$736
- Abiomed$173
- AbbVie$155
- DJO, LLC$108
- plus $542 from 13 others
What the payments were for
- Travel & lodging$1,24529%
- Food & beverage$1,85043%
- Education$1,20028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $1,419 |
| Peerless Surgical Inc. | 3 | $1,163 |
| Amgen | 14 | $736 |
| Abiomed | 9 | $173 |
| AbbVie(2 entities) | 3 | $155 |
| DJO, LLC | 1 | $108 |
| Pacira Pharmaceuticals Incorporated | 1 | $88 |
| Hydrocision, Inc. | 1 | $86 |
| Inari Medical, Inc. | 3 | $77 |
| MVP Orthopedics Inc | 1 | $72 |
| Lilly USA, LLC | 2 | $48 |
| GSK | 2 | $44 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Bioventus LLC | 1 | $21 |
| Bayer | 1 | $20 |
| Pfizer | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,295 in reported general payments places this provider in the 70th percentile of 158 sports medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 12 | $1,244 |
| Meloxicam | 261 | $963 |
| Diclofenac Sodium | 17 | $601 |
| Methylprednisolone | 30 | $212 |
| Gabapentin | 12 | $57 |
| Tramadol Hcl | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Sylva
- Brian WatermanWinston Salem$360K
- Allston StubbsWinston Salem$184K
- Robert BoykinAsheville$126K
- Tally EddingsAsheville$109K
- Rebecca BassettGreensboro$69K
- Wallace HarrisAsheville$58K
- Alan ReynoldsGreensboro$54K
- Fletcher PreussCharlotte$53K
- Anthony MaroisSherrills Ford$47K
- Andrew KerstenHendersonville$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.